Billiontoone (NASDAQ:BLLN) Price Target Cut to $130.00 by Analysts at JPMorgan Chase & Co.Market Beat·2 hours agoBLLN-3889.00%
BillionToOne: Buy Rating Reaffirmed on Strong Q2 Beat, 2027 Growth Visibility, and Attractive Valuation vs. High-Growth PeersTip Ranks·5 hours agoBLLN-3889.00%
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga_article·6 hours agoBLLN-3889.00%CELZ+7195.00%
BillionToOne Stock (BLLN) Falls After Hours: Here's What's Driving the Movebenzinga_article·17 hours agoBLLN-3889.00%
Billiontoone | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 109.45 MEarnings Watch·1 day ago, 04:12 PMBLLN-3889.00%
12 Health Care Stocks Moving In Wednesday's After-Market Sessionbenzinga_article·1 day ago, 04:06 PMCELZ+7195.00%BLLN-3889.00%
BillionToOne Q2 FY26 net income turns to USD 8.1 million; revenue rises 64% to USD 109.4 millionPUBT·1 day ago, 03:15 PMBLLN-3889.00%
BillionToOne Chief Product Officer Sakakibara Shan Riku disposes of 4,000 common shares worth $560,840PUBT·2 days ago, 03:34 PMBLLN-3889.00%
Billiontoone (NASDAQ:BLLN) Reaches New 12-Month High - Should You Buy?Market Beat·Jul 30 at 03:00 PMBLLN-3889.00%
GeneDx Stock And 2 Testing Companies In Focus After Cyclospora OutbreakSimplywall·Jul 27 at 02:13 PMBLLN-3889.00%WGS-46.00%
Capital Rotations: A Record Biotech IPO and the Surging European Defense ETFGlobal Report·Jul 21 at 04:13 AMPBLS+195.00%GIS+39.00%
BillionToOne SVP Sales Nancy JoAnn Johnson disposes of 14,199 common shares worth $1.82 millionPUBT·Jul 20 at 06:38 PMBLLN-3889.00%
